Patents by Inventor O'Neil Wiggan

O'Neil Wiggan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for live attenuated viruses
    Patent number: 11197923
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: December 14, 2021
    Assignee: Takeda Vaccines, Inc.
    Inventors: Dan Stinchcomb, Jorge E. Osorio, O'Neil Wiggan
  • METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES
    Publication number: 20200108136
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Application
    Filed: November 22, 2019
    Publication date: April 9, 2020
    Inventors: Dan STINCHCOMB, Jorge E. OSORIO, O'Neil WIGGAN
  • Methods and compositions for live attenuated viruses
    Patent number: 10525120
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: January 7, 2020
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Dan Stinchcomb, Jorge E. Osorio, O'Neil Wiggan
  • COMPOSITIONS, METHODS AND USES FOR INDUCING VIRAL GROWTH
    Publication number: 20180251737
    Abstract: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally related to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
    Type: Application
    Filed: December 28, 2017
    Publication date: September 6, 2018
    Inventors: Dan T. Stinchcomb, Jill A. Livengood, O'Neil Wiggan, Richard Kinney, Jorge Osorio
  • Compositions, methods and uses for inducing viral growth
    Patent number: 9890362
    Abstract: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally relate to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: February 13, 2018
    Assignee: Takeda Vaccines, Inc.
    Inventors: Dan T Stinchcomb, Jill A. Livengood, O'Neil Wiggan, Richard Kinney, Jorge Osorio
  • METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES
    Publication number: 20170100474
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Application
    Filed: July 22, 2016
    Publication date: April 13, 2017
    Inventors: Dan Stinchomb, Jorge E. Osorio, O'Neil Wiggan
  • COMPOSITIONS, METHODS AND USES FOR INDUCING VIRAL GROWTH
    Publication number: 20150010983
    Abstract: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally related to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
    Type: Application
    Filed: September 19, 2014
    Publication date: January 8, 2015
    Inventors: Dan T. Stinchcomb, Jill A. Livengood, O'Neil Wiggan, Richard Kinney, Jorge Osorio
  • Compositions, methods and uses for inducing viral growth
    Patent number: 8871487
    Abstract: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally related to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: October 28, 2014
    Assignee: Takeda Vaccines, Inc.
    Inventors: Dan T. Stinchcomb, Jill A. Livengood, O'Neil Wiggan, Richard Kinney, Jorge Osorio
  • METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES
    Publication number: 20140302091
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Application
    Filed: November 18, 2011
    Publication date: October 9, 2014
    Inventors: Dan T. Stinchcomb, Jorge E. Osorio, O'Neil Wiggan
  • Methods and compositions for live attenuated viruses
    Patent number: 8084039
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: December 27, 2011
    Assignee: Inviragen, Inc.
    Inventors: Dan T. Stinchcomb, Jorge E. Osorio, O'Neil Wiggan
  • COMPOSITIONS, METHODS AND USES FOR INDUCING VIRAL GROWTH
    Publication number: 20100144015
    Abstract: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally related to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
    Type: Application
    Filed: December 4, 2009
    Publication date: June 10, 2010
    Inventors: Dan T. Stinchcomb, Jill A. Livengood, O'Neil Wiggan, Richard Kinney, Jorge Osorio
  • METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES
    Publication number: 20080248551
    Abstract: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
    Type: Application
    Filed: April 4, 2008
    Publication date: October 9, 2008
    Inventors: Dan T. Stinchcomb, Jorge E. Osorio, O'Neil Wiggan